Comperat E. Re: Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guerin (BCG) in BCG-naive High-risk Non-muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials. Eur Urol 2026 May 15:S0302-2838(26)01994-9. doi: 10.1016/j.eururo.2026.
PMID: 42140860